Collectively, the promotional effects of miR-29b/Sp1/FUT4 regulatory axis on AML LSCs progression could be partially mediated through fucosylated CD44-mediated Wnt/β-catenin signaling. The gene discussed is SP1; the disease is acute myeloid leukemia.